Sero-prevalence of brucellosis among clinically suspect human cases presenting at health facilities in Namibia from 2012 to 2017

dc.contributor.authorMadzingira, Oscar
dc.contributor.authorFasina, Folorunso Oludayo
dc.contributor.authorKalinda, Chester
dc.contributor.authorVan Heerden, Henriette
dc.date.accessioned2022-08-24T10:41:44Z
dc.date.available2022-08-24T10:41:44Z
dc.date.issued2021-03
dc.description.abstractOBJECTIVE : This study estimated seroprevalence among human patients presenting with brucellosis-like symptoms in Namibia using serological test results from 2012-2017. METHODS : Presumptive cases were screened using a brucellosis commercial agglutination test kit. RESULTS : Apparent prevalence of human brucellosis was 11.64% (113/971, 95% CI: 9.77-13.81), while active infections were estimated at 6.90% (67/971, 95% CI: 5.47-8.67). Seropositive cases were clustered in the 30-40 year age group, and in females (64%) than males (36%) (z = -5.24, p < 0.01). Age (RR: 0.980 95% CI: 0.907-1.05) and gender (RR: 0.800, 95% CI: 0.598-1.069) were not risk factors for Brucella infection.en_US
dc.description.departmentVeterinary Tropical Diseasesen_US
dc.description.librarianhj2022en_US
dc.description.urihttp://www.elsevier.com/journals/biomedical-and-environmental-sciences/0895-3988en_US
dc.identifier.citationMadzingira, O., Fasina, F.O., Kalinda, C., Van Heerden, H. Seroprevalence of Brucellosis among Clinically Suspected Human Cases Presenting at Health Facilities in Namibia from 2012 to 2017. Biomedical and Environmental Sciences, 2021, 34(3): 232-235. doi: 10.3967/bes2021.029.en_US
dc.identifier.issn0895-3988 (print)
dc.identifier.issn2214-0190 (online)
dc.identifier.other10.3967/bes2021.029
dc.identifier.urihttps://repository.up.ac.za/handle/2263/86939
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rights© 2021 Elsevier Ltd. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Biomedical and Environmental Sciences. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Biomedical and Environmental Sciences, vol. 34, no. 3, pp. 232-235, 2021. doi : 10.3967/bes2021.029.en_US
dc.subjectBrucellaen_US
dc.subjectHuman brucellosisen_US
dc.subjectNamibiaen_US
dc.subjectSeroprevalenceen_US
dc.titleSero-prevalence of brucellosis among clinically suspect human cases presenting at health facilities in Namibia from 2012 to 2017en_US
dc.typePostprint Articleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Madzingira_Serprevalence_2021.pdf
Size:
280.74 KB
Format:
Adobe Portable Document Format
Description:
Postprint Article
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (Veterinary Tropical Diseases)
Research Articles (University of Pretoria)
Simple item page